|
"lu yen shen"的相關文件
顯示項目 71-80 / 109 (共11頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2010 |
The Prevalence and Assessment of Erbb2-Positive Breast Cancer in Asia: A Literature Survey
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2010 |
Vinorelbine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as Effective Palliative Chemotherapy for Breast Cancer Patients with Acute Disseminated Intravascular Coagulation
|
林柏翰; 盧彥伸; 林璟宏; 黃俊升; 鄭安理; 葉坤輝; LIN, PO-HAN; LU, YEN-SHEN; LIN, CHING-HUNG; HUANG, CHIUN-SHENG; CHENG, ANN-LII; YEH, KUN-HUEI |
| 國立臺灣大學 |
2009 |
Induction of Bim Expression Contributes to the Antitumor Synergy between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal- Regulated Kinase Kinase Inhibitor Ci-1040 in Hepatocellular Carcinoma
|
歐大諒; 沈盈君; 梁嘉德; 劉俊揚; 俞松良; 盧彥伸; 許駿; 鄭安理; OU, DA-LIANG; SHEN, YING-CHUN; LIANG, JA-DER; LIOU, JUN-YANG; YU, SUNG-LIANG; LU, YEN-SHEN; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Management of Her2-Positive Breast Cancer in Asia:Consensus Statement from the Asian Oncology Summit 2
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Molecular Subtypes of Breast Cancer Emerging in Young Women in Taiwan: Evidence for More Than Just Westernization as a Reason for the Disease in Asia
|
林璟宏; 盧彥伸; 黃俊升; 沈盈君; 郭頌鑫; 劉敏; 張金堅; 鄭安理; LIN, CHING-HUNG; LU, YEN-SHEN; HUANG, CHIUN-SHENG; SHEN, YING-CHUN; KUO, SUNG-HSIN; LIU, JACQUELINE MING; CHANG, KING-JEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Poor Response to Systemic Chemotherapy in Metaplastic Carcinoma of Breast
|
盧彥伸; 黃俊升; 鄭安理; LU, YEN-SHEN; HUANG, CHIUN-SHENG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Resource-Based Data Availability for Erbb2-Driven Breast Cancer in Asian Women: Experts' Opinion
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Locoregional Therapy Improves Survival for Metastatic Breast Cancer Patients? Benefit Remains Questionable!
|
張端瑩; 林璟宏; 盧彥伸; CHANG, DWAN-YING; LIN, CHING-HUNG; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
顯示項目 71-80 / 109 (共11頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目
|
